Zhengye Biotechnology Holding revenue was $29.73M for the trailing 12 months ending Dec 31, 2023, with -33.6% growth year over year. Quarterly revenue for the quarter (Q4 2023) ending on Dec 31, 2023 was N/A, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ZYBT annual revenue was $29.9M, with -20.1% growth year-over-year.
ZYBT past revenue growth
How has ZYBT's revenue growth performed historically?
Zhengye Biotechnology Holding (NASDAQ: ZYBT) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Zhengye Biotechnology Holding's revenue was N/A.
What was Zhengye Biotechnology Holding's revenue in 2023?
Zhengye Biotechnology Holding's annual revenue for the twelve months ending Dec 31, 2023 was $29.85 million, a 20.06% decrease year over year.
How much does Zhengye Biotechnology Holding make in a day?
Based on Zhengye Biotechnology Holding annual revenue for the past one years, ZYBT makes an average of $81,786.42 per day.
What was Zhengye Biotechnology Holding's annual revenue growth in the past year?
As of Q2 2025, Zhengye Biotechnology Holding's revenue has grown -20.06% year over year. This is 1,381.2 percentage points lower than the US Biotechnology industry revenue growth rate of 1,361.15%. Zhengye Biotechnology Holding's revenue in the past year totaled $29.73 million.
How much does Zhengye Biotechnology Holding make in a year?
Zhengye Biotechnology Holding's revenue by year for the past one years is:
Zhengye Biotechnology Holding's revenue for the twelve months ending Dec 31, 2023 was $29.85 million, a 20.06% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.